房颤导管消融与死亡或卒中的关联
中位随访4.5±2.8年,消融组主要复合终点(全因死亡或卒中)风险显著低于对照组(HR 0.58,95%CI 0.48-0.69),主要源于全因死亡风险降低(HR 0.51,95%CI 0.41-0.63)。
要点
- 房颤导管消融与全因死亡或卒中复合终点风险降低相关(HR 0.58)。
- 全因死亡风险显著降低(HR 0.51,95%CI 0.41-0.63)。
- 卒中风险降低有倾向但未达统计学显著(HR 0.75,95%CI 0.53-1.07)。
核心结论
- 房颤导管消融与全因死亡或卒中复合终点风险降低相关,主要由全因死亡显著降低驱动。
研究设计与样本
- 回顾性队列研究,纳入2008-2018年瑞典三家电生理中心5628例首次房颤消融患者。
主要发现
- 消融组更健康(平均CHA2DS2-VASc评分1.4±1.4 vs 1.6±1.5,p<0.001),收入更高(288 vs 212 KSEK/年,p<0.001),大学教育更普遍(45.1% vs 28.9%,p<0.001)。
- 平均随访4.5±2.8年,匹配后消融组主要复合终点风险更低(HR 0.58,95%CI 0.48-0.69)。
- 全因死亡风险显著降低(HR 0.51,95%CI 0.41-0.63)。
- 卒中风险降低呈倾向但未达显著(HR 0.75,95%CI 0.53-1.07)。
临床怎么用
- 对于符合条件的房颤患者,导管消融可能降低全因死亡或卒中的长期风险,但需结合个体特征评估。
局限性
- 回顾性设计,消融组基线更健康且社会经济状况更好,倾向评分匹配可能无法完全消除混杂。
- 卒中风险降低未达统计学显著,需更长时间随访验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Catheter ablation of atrial fibrillation effectively reduces symptomatic burden. However, its long-term effect on mortality and stroke is unclear. We investigated if patients with atrial fibrillation who undergo catheter ablation have lower risk for all-cause mortality or stroke than patients who are managed medically. METHODS: We retrospectively included 5628 consecutive patients who underwent first-time catheter ablation for atrial fibrillation between 2008 and 2018 at three major Swedish electrophysiology units. Control individuals with an atrial fibrillation diagnosis but without previous stroke were selected from the Swedish National Patient Register, resulting in a control group of 48 676 patients. Propensity score matching was performed to produce two cohorts of equal size (n=3955) with similar baseline characteristics. The primary endpoint was a composite of all-cause mortality or stroke. RESULTS: Patients who underwent catheter ablation were healthier (mean CHA2DS2-VASc score 1.4±1.4 vs 1.6±1.5, p<0.001), had a higher median income (288 vs 212 1000 Swedish krona [KSEK]/year, p<0.001) and had more frequently received university education (45.1% vs 28.9%, p<0.001). Mean follow-up was 4.5±2.8 years. After propensity score matching, catheter ablation was associated with lower risk for the combined primary endpoint (HR 0.58, 95% CI 0.48 to 0.69). The result was mainly driven by a decrease in all-cause mortality (HR 0.51, 95% CI 0.41 to 0.63), with stroke reduction showing a trend in favour of catheter ablation (HR 0.75, 95% CI 0.53 to 1.07). CONCLUSIONS: Catheter ablation of atrial fibrillation was associated with a reduction in the primary endpoint of all-cause mortality or stroke. This result was driven by a marked reduction in all-cause mortality.
引用
- Akerström, Hutter, Charitakis, et al. Association between catheter ablation of atrial fibrillation and mortality or stroke. Heart. 2024. PMID: 37657914. doi:10.1136/heartjnl-2023-322883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。